Product nameAnti-SLPI antibody - Aminoterminal end
See all SLPI primary antibodies
DescriptionRabbit polyclonal to SLPI - Aminoterminal end
Tested applicationsSuitable for: WBmore details
Species reactivityReacts with: Human
Synthetic peptide based on the aminoterminal end of human SLPI.(Please note: the amino acid sequence is proprietary) (Peptide available as ab46833.)
Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Storage bufferpH: 7.40
Preservative: 0.05% Sodium azide
Constituents: PBS, 50% Glycerol, 2.9% Sodium chloride
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab46763 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000 - 1/5000. Predicted molecular weight: 14 kDa.
A recommended starting concentration for Western blots is 1/1000 when using colorimetric substrates such as BCIP/NBT, and 1/5000 for chemiluminescent substrates. Dilution optimised using Chromogenic detection.
FunctionAcid-stable proteinase inhibitor with strong affinities for trypsin, chymotrypsin, elastase, and cathepsin G. May prevent elastase-mediated damage to oral and possibly other mucosal tissues.
Tissue specificityMucous fluids.
Sequence similaritiesContains 2 WAP domains.
- Information by UniProt
- ALK 1 antibody
- ALK1 antibody
- ALP antibody
All lanes : Anti-SLPI antibody - Aminoterminal end (ab46763) at 1/1000 dilution
Lane 1 : Recombinant Human SLP I at 0.04 µg
Lane 2 : Recombinant Human SLP I at 0.02 µg
Lane 3 : Recombinant Human SLP I at 0.01 µg
Lane 4 : Recombinant Human SLP I at 0.004 µg
Lane 5 : Recombinant Human SLP I at 0.001 µg
Predicted band size: 14 kDa
Observed band size: 15 kDa why is the actual band size different from the predicted?
This product has been referenced in:
- Klimenkova O et al. A lack of secretory leukocyte protease inhibitor (SLPI) causes defects in granulocytic differentiation. Blood 123:1239-49 (2014). Human . Read more (PubMed: 24352879) »
- Yang Y et al. Quantitative proteomic analysis of oral brush biopsies identifies secretory leukocyte protease inhibitor as a promising, mechanism-based oral cancer biomarker. PLoS One 9:e95389 (2014). WB ; Human . Read more (PubMed: 24748380) »